• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. HENRY SCHEIN HCG DIPSTICK URINE; VISUAL, PREGNANCY HCG, PRESCRIPTION USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. HENRY SCHEIN HCG DIPSTICK URINE; VISUAL, PREGNANCY HCG, PRESCRIPTION USE Back to Search Results
Model Number FHC-101
Medical Device Problem Code False Positive Result (1227)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/01/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
B3 - date of event: was not provided.The customer indicated the false results were prior to (b)(6) 2024.Results pending completion of the investigation.
 
Event or Problem Description
The customer reported receiving 14 false positive hcg results while using henry schein one step+ hcg urine strip tests.The customer was unable to confirm the number of patients tested as some were tested twice.Each patient provided a fresh urine sample which was tested, and the results were read at 3 minutes.A false positive result was obtained.Confirmatory testing using different medline kits were then tested which resulted negative.No further information was provided.No adverse events were reported.See mdr 2027969-2024-00172 for the events pertaining to patients that had 2 false positive results.
 
Event or Problem Description
The customer reported receiving 14 false positive hcg results while using henry schein one step+ hcg urine strip tests.The customer was unable to confirm the number of patients tested as some were tested twice.Each patient provided a fresh urine sample which was tested, and the results were read at 3 minutes.A false positive result was obtained.Confirmatory testing using different medline kits were then tested which resulted negative.No further information was provided.No adverse events were reported.See mdr 2027969-2024-00172 for the events pertaining to patients that had 2 false positive results.
 
Additional Manufacturer Narrative
B3 - date of event: was not provided.The customer indicated the false results were prior to (b)(6) 2024.D4 - expiration date: was updated from blank to 15oct2025.D4 - primary udi number: was updated from blank to "(b)(4)".H4 - device mfg date: was updated from blank to 17oct2023.Investigation conclusion: retained devices from the reported lot number were tested with hcg-negative clinical urine samples.The results were read at 3 and 4 minutes and all devices yielded valid negative results.No false positive results were observed during in-house testing.The case details were reviewed along with the complaint history for the reported issue and no indications of a systemic issue were identified.Manufacturing batch record review did not uncover any relevant non-conformances and found that the lot met quality control specifications.Review of the risk management report for this product found that the reported issue is within the risk profile for this device; no new hazard has been identified.A root cause could not be determined from the available information as the reported issue was not replicated during testing of retention product.Complaints are tracked and trended on a monthly basis.Per the package insert: very low levels of hcg (less than 50 miu/ml) are present in urine specimen shortly after implantation.However, because a significant number of first trimester pregnancies terminate for natural reasons, a test result that is weakly positive should be confirmed by retesting with a first morning urine specimen collected 48 hours later.A number of conditions other than pregnancy, including trophoblastic disease and certain non-trophoblastic neoplasms including testicular tumors, prostate cancer, breast cancer, and lung cancer, cause elevated levels of hcg.Therefore, the presence of hcg in urine should not be used to diagnose pregnancy unless these conditions have been ruled out.This test provides a presumptive diagnosis for pregnancy.A confirmed pregnancy diagnosis should only be made by a physician after all clinical and laboratory findings have been evaluated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HENRY SCHEIN HCG DIPSTICK URINE
Common Device Name
VISUAL, PREGNANCY HCG, PRESCRIPTION USE
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9942 mesa rim rd
san diego CA 92121
Manufacturer Contact
monika burrell
9942 mesa rim rd
san diego, CA 92121
8588052506
MDR Report Key20409302
Report Number2027969-2024-00173
Device Sequence Number12735706
Product Code JHI
UDI-Device Identifier10304040024093
UDI-Public(01)10304040024093(17)251015(10)0000789150
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
K993203
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 11/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/15/2025
Device Model NumberFHC-101
Device Catalogue Number9004072
Device Lot Number0000789150
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/12/2024
Supplement Date Received by Manufacturer11/04/2024
Initial Report FDA Received Date10/09/2024
Supplement Report FDA Received Date11/04/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured10/17/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexFemale
-
-